Specializes in providing safe, high-quality treatments for patients requiring customized formulations for their care.
201 - 500
π° Private Equity Round on 2015-01
April 3
201 - 500
πΊπΈ United States β Remote
π° Private Equity Round on 2015-01
β° Full Time
π Senior
π‘ Marketing
π½ H1B Visa Sponsor